Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders

por Pospiskova, Jana, Smolej, Lukas, Belada, David, Simkovic, Martin, Motyckova, Monika, Sykorova, Alice, Stepankova, Pavla, Zak, Pavel
Publicado 2019

P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma

por Mocikova, Heidi, Markova, Jana, Gaherova, Lubica, Maco, Maria, Sýkorová, Alice, Belada, David, Lukášová, Marie, Prochazka, Vit, Duras, Juraj, Kozak, Tomas
Publicado 2022

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry

por Mocikova, Heidi, Pytlík, Robert, Benesova, Katerina, Janikova, Andrea, Duras, Juraj, Sykorova, Alice, Steinerova, Katerina, Prochazka, Vit, Campr, Vit, Belada, David, Trneny, Marek
Publicado 2022

P047: Predictive role of the Hodgkin lymphoma-associated cytokines: a prospective study of the Czech Hodgkin Study Group

por Prochazka, Vit, Mocikova, Heidi, Sykorova, Alice, Markova, Jana, Lukášová, Marie, Gaherova, Lubica, Kredatusova, Alexandra, Kriegova, Eva, Maco, Maria, Kozak, Tomas, Belada, David, Papajik, Tomas
Publicado 2022

Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic

por Obr, Ales, Benesova, Katerina, Janikova, Andrea, Mocikova, Heidi, Belada, David, Hruskova, Andrea, Vockova, Petra, Salek, David, Sykorova, Alice, Furst, Tomas, Malarikova, Diana, Papajik, Tomas, Trneny, Marek, Klener, Pavel
Publicado 2022

Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R‐CHOP

por Procházka, Vít, Belada, David, Janíková, Andrea, Benešová, Kateřina, Mociková, Heidi, Ďuraš, Juraj, Pirnos, Jan, Kopečková, Kateřina, Campr, Vít, Fürst, Tomáš, Pytlík, Robert, Sýkorová, Alice, Michalka, Jozef, Dlouhá, Jitka, Papajík, Tomáš, Trněný, Marek
Publicado 2020

Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia

por Král, Zdeněk, Michalka, Jozef, Móciková, Heidi, Marková, Jana, Sýkorová, Alice, Belada, David, Jungová, Alexandra, Vokurka, Samuel, Lukášová, Marie, Procházka, Vít, Ďuraš, Juraj, Hájek, Roman, Dušek, Ladislav, Drgoňa, Ľuboš, Ladická, Miriam, Ballová, Veronika, Vranovský, Andrej
Publicado 2019

P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.

por Michalka, Jozef, Marková, Jana, Gahérová, Ľubica, Maco, Mária, Procházka, Vít, Kořen, Jan, Sýkorová, Alice, Štěpánková, Pavla, Steinerová, Kateřina, Mohammad, Lekaa, Ďuraš, Juraj, Velacková, Barbora, Doležal, Tomáš, Benešová, Kateřina, Lukášová, Marie, Janíková, Andrea, Král., Zdeněk., Móciková, Heidi
Publicado 2022

Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patien...

por Hutchings, Martin, Radford, John, Ansell, Stephen M., Illés, Árpád, Sureda, Anna, Connors, Joseph M., Sýkorová, Alice, Shibayama, Hirohiko, Abramson, Jeremy S., Chua, Neil S., Friedberg, Jonathan W., Kořen, Jan, LaCasce, Ann Steward, Molina, Lysiane, Engley, Gerald, Fenton, Keenan, Jolin, Hina, Liu, Rachael, Gautam, Ashish, Gallamini, Andrea
Publicado 2021